VANCOMYCIN PROTEIN-BINDING IN PATIENTS WITH INFECTIONS CAUSED BY STAPHYLOCOCCUS-AUREUS

被引:41
作者
ALBRECHT, LM
RYBAK, MJ
WARBASSE, LH
EDWARDS, DJ
机构
[1] WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DETROIT,MI 48202
[2] WAYNE STATE UNIV,SCH MED,DETROIT,MI 48201
[3] DETROIT RECEIVING HOSP & UNIV HLTH CTR,DEPT PHARM SERV,DETROIT,MI 48201
[4] DETROIT RECEIVING HOSP & UNIV HLTH CTR,DEPT MED,DETROIT,MI 48201
[5] DETROIT RECEIVING HOSP & UNIV HLTH CTR,DEPT PHARM SERV,DETROIT,MI 48201
来源
DICP-THE ANNALS OF PHARMACOTHERAPY | 1991年 / 25卷 / 7-8期
关键词
BURN PATIENTS; PHARMACOKINETICS;
D O I
10.1177/106002809102500701
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The protein binding of vancomycin has been reported to range from less than 10 percent to 82 percent. We examined the binding of vancomycin in 34 patients (14 intravenous drug abusers, 10 burn patients, and 10 control patients) with Staphylococcus aureus infections. Blood samples were collected serially over an 8- or 12-hour dosing interval following a one-hour infusion. In vitro studies were also performed using albumin solutions of varying concentrations. Binding characteristics were determined through ultrafiltration with vancomycin concentrations analyzed by fluorescence polarization immunoassay. The unbound fraction of vancomycin ranged from 0.41 to 0.77 with a mean of 0.54 +/- 0.08. Unbound fraction was significantly correlated with serum albumin concentration (r = -0.344, p < 0.046) and renal clearance (r = 0.394, p < 0.021) but not with total body clearance or volume of distribution. In vitro data also showed an association between albumin concentration and unbound fraction (r = 0.94, p < 0.017). Although vancomycin protein binding changes with serum albumin, this finding may have limited clinical significance.
引用
收藏
页码:713 / 715
页数:3
相关论文
共 14 条
  • [1] VANCOMYCIN SERUM-PROTEIN BINDING DETERMINATION BY ULTRAFILTRATION
    ACKERMAN, BH
    TAYLOR, EH
    OLSEN, KM
    ABDELMALAK, W
    PAPPAS, AA
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (04): : 300 - 303
  • [2] ALBRECHT LM, 1988, THER DRUG MONIT, V10, P85, DOI 10.1097/00007691-198801000-00015
  • [3] POSTBURN SERUM DRUG-BINDING AND SERUM-PROTEIN CONCENTRATIONS
    BLOEDOW, DC
    HANSBROUGH, JF
    HARDIN, T
    SIMONS, M
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (02) : 147 - 151
  • [4] VANCOMYCIN ELIMINATION IN PATIENTS WITH BURN INJURY
    BRATER, DC
    BAWDON, RE
    ANDERSON, SA
    PURDUE, GF
    HUNT, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) : 631 - 634
  • [5] VANCOMYCIN DISPOSITION - THE IMPORTANCE OF AGE
    CUTLER, NR
    NARANG, PK
    LESKO, LJ
    NINOS, M
    POWER, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (06) : 803 - 810
  • [6] DANIELS JC, 1974, J TRAUMA, V14, P137
  • [7] ROLE OF PHARMACOKINETICS IN THE OUTCOME OF INFECTIONS
    DRUSANO, GL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) : 289 - 297
  • [8] ALTERED VANCOMYCIN DOSE VS SERUM CONCENTRATION RELATIONSHIP IN BURN PATIENTS
    GARRELTS, JC
    PETERIE, JD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (01) : 9 - 13
  • [9] VANCOMYCIN PHARMACOKINETICS, RENAL HANDLING, AND NONRENAL CLEARANCES IN NORMAL HUMAN-SUBJECTS
    GOLPER, TA
    NOONAN, HM
    ELZINGA, L
    GILBERT, D
    BRUMMETT, R
    ANDERSON, JL
    BENNETT, WM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (05) : 565 - 570
  • [10] SINGLE-DOSE KINETICS OF INTRAVENOUS VANCOMYCIN
    KROGSTAD, DJ
    MOELLERING, RC
    GREENBLATT, DJ
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (04) : 197 - 201